Nimvastid
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nimvastid, covering 2025-07-17 to 2025-07-17. Get the full timeline:
Most recent: EMA Authorised: Nimvastid (rivastigmine) — Krka, d.d., Novo mesto
1 regulatory and trial event tracked for Nimvastid, covering 2025-07-17 to 2025-07-17. Get the full timeline:
Most recent: EMA Authorised: Nimvastid (rivastigmine) — Krka, d.d., Novo mesto